i3 Drug Safety Biographies

Paul Dolin leads i3’s International Drug Safety team and is based in Maidenhead, England. He has an extensive background in drug safety and risk management. Prior of joining i3, Paul held a number of senior positions in the pharmaceutical industry, including Global Head of Drug Safety and Risk Management (Hoffmann-La Roche), Global Head of Medical Evaluations (Hoffmann-La Roche) and Senior Director of Worldwide Epidemiology (GSK).

He holds a Master of Public Health and a Doctorate from Oxford University, and has first authored more than 30 papers in international peer-review journals. He has developed numerous risk management plans for submission to the EMEA and FDA advisory panels. Paul is a member of the CIOMS pharmacovigilance working groups.